Ilsung Pharmaceuticals Co., Ltd. (KOSE:A003120) announces a share repurchase program. Under the program, the company will repurchase up to KRW 15,000 million worth of its shares, pursuant to a trust contract with Mirae Asset Securities. The purpose of the program is to stabilize stock price and enhance the shareholder value.

The program will expire on August 11, 2023. As of February 12, 2023, the company had 1,079,302 shares in treasury within scope available for dividend and had 97,865 shares in treasury under other capacities.